INOVIQ LTD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.55 AUD | -5.17% |
|
+14.58% | -17.29% |
| 04-19 | INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test | MT |
| 04-15 | Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INOVIQ LTD | Other Biotechnology & Medical Research | -5.17% | +14.58% | -17.29% | +18.28% | -3.51% | 35.48M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- IIQ Stock
- Charts INOVIQ Ltd
- Comparison Chart
